Literature DB >> 7913914

Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage.

L Rénia1, M M Rodrigues, V Nussenzweig.   

Abstract

Malaria liver forms are the target of antibody or T-cell-mediated immune mechanisms induced by previous or subsequent developmental stages of the parasite. The potential for vaccine development of antigens expressed exclusively in the liver stages has not been fully explored partly because of the lack of an experimental animal model. Here we show that protective immunity against sporozoite-induced infection with Plasmodium yoelii and P. berghei can be obtained by intrasplenic injection of a small number of liver stages of the parasites. The serum of the protected animals did not contain antibodies against sporozoites, liver or blood stage malaria parasites. Protective immunity was abolished by depletion of either CD4+ or CD8+ T cells from the vaccinated mice before challenge.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913914      PMCID: PMC1414842     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Plasmodium yoelii: quantification of the exoerythrocytic stages based on the use of ribosomal RNA probes.

Authors:  G Arreaza; V Corredor; F Zavala
Journal:  Exp Parasitol       Date:  1991-01       Impact factor: 2.011

2.  Successful immunization against the sexual stages of Plasmodium gallinaceum.

Authors:  R W Gwadz
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

3.  Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.

Authors:  J H Playfair; J B De Souza; B J Cottrell
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

Review 4.  Exoerythrocytic development of malarial parasites.

Authors:  J F Meis; J P Verhave
Journal:  Adv Parasitol       Date:  1988       Impact factor: 3.870

5.  Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro.

Authors:  M C Seguin; W R Ballou; C A Nacy
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

6.  Malaria transmission blocked by immunisation with gametes of the malaria parasite.

Authors:  R Carter; D H Chen
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

7.  Effect of irradiation on Plasmodium sporozoites depends on the species of hepatocyte infected.

Authors:  A Nüssler; J Y Follezou; F Miltgen; D Mazier
Journal:  Trop Med Parasitol       Date:  1989-12

8.  Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.

Authors:  S Khusmith; Y Charoenvit; S Kumar; M Sedegah; R L Beaudoin; S L Hoffman
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

9.  Merozoite vaccination of douroucouli monkeys against falciparum malaria.

Authors:  G H Mitchell; W H Richards; G A Butcher; S Cohen
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

10.  Morphology and function of isolated hepatocytes transplanted into rat spleen.

Authors:  M Mito; H Ebata; M Kusano; T Onishi; T Saito; S Sakamoto
Journal:  Transplantation       Date:  1979-12       Impact factor: 4.939

View more
  12 in total

1.  Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.

Authors:  J A Vaughan; L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay.

Authors:  Jing Zhou; Alaina Kaiser; Colin Ng; Rachel Karcher; Tim McConnell; Patrick Paczkowski; Cristina Fernandez; Min Zhang; Sean Mackay; Moriya Tsuji
Journal:  Hum Vaccin Immunother       Date:  2017-07-03       Impact factor: 3.452

3.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 4.  A retrospective evaluation of the role of T cells in the development of malaria vaccine.

Authors:  Moriya Tsuji
Journal:  Exp Parasitol       Date:  2009-11-26       Impact factor: 2.011

5.  Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.

Authors:  Lbachir BenMohamed; Alan Thomas; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 6.  Antigens for pre-erythrocytic malaria vaccines: building on success.

Authors:  C Speake; P E Duffy
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

7.  Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice.

Authors:  Lisa A Purcell; Stephanie K Yanow; Moses Lee; Terry W Spithill; Ana Rodriguez
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

8.  P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model.

Authors:  Philip Eckhoff
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

9.  CSP--a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes.

Authors:  Saidou Balam; Jackeline F Romero; Silayuv E Bongfen; Philippe Guillaume; Giampietro Corradin
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

10.  A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus.

Authors:  Sarene Koh; Noriko Shimasaki; Rossarin Suwanarusk; Zi Zong Ho; Adeline Chia; Nasirah Banu; Shanshan Wu Howland; Alice Soh Meoy Ong; Adam J Gehring; Hans Stauss; Laurent Renia; Matti Sällberg; Dario Campana; Antonio Bertoletti
Journal:  Mol Ther Nucleic Acids       Date:  2013-08-13       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.